OPKO Health Total Liabilities and Share Holders Equity 2010-2024 | OPK

OPKO Health total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
OPKO Health Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $2,012
2022 $2,167
2021 $2,400
2020 $2,473
2019 $2,309
2018 $2,451
2017 $2,590
2016 $2,767
2015 $2,799
2014 $1,268
2013 $1,392
2012 $290
2011 $229
2010 $78
2009 $87
OPKO Health Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-06-30 $1,980
2024-03-31 $1,974
2023-12-31 $2,012
2023-09-30 $2,057
2023-06-30 $2,159
2023-03-31 $2,170
2022-12-31 $2,167
2022-09-30 $2,225
2022-06-30 $2,370
2022-03-31 $2,307
2021-12-31 $2,400
2021-09-30 $2,418
2021-06-30 $2,422
2021-03-31 $2,520
2020-12-31 $2,473
2020-09-30 $2,371
2020-06-30 $2,324
2020-03-31 $2,233
2019-12-31 $2,309
2019-09-30 $2,370
2019-06-30 $2,456
2019-03-31 $2,575
2018-12-31 $2,451
2018-09-30 $2,481
2018-06-30 $2,531
2018-03-31 $2,579
2017-12-31 $2,590
2017-09-30 $2,722
2017-06-30 $2,769
2017-03-31 $2,760
2016-12-31 $2,767
2016-09-30 $2,800
2016-06-30 $2,774
2016-03-31 $2,793
2015-12-31 $2,799
2015-09-30 $3,016
2015-06-30 $1,525
2015-03-31 $1,512
2014-12-31 $1,268
2014-09-30 $1,295
2014-06-30 $1,327
2014-03-31 $1,356
2013-12-31 $1,392
2013-09-30 $1,383
2013-06-30 $641
2013-03-31 $654
2012-12-31 $290
2012-09-30 $250
2012-06-30 $230
2012-03-31 $232
2011-12-31 $229
2011-09-30 $151
2011-06-30 $160
2011-03-31 $176
2010-12-31 $78
2010-09-30 $68
2010-06-30 $68
2010-03-31 $87
2009-12-31 $87
2009-09-30 $84
2009-06-30 $60
2009-03-31 $19
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.130B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $233.063B 27.94
Intuitive Surgical (ISRG) United States $171.313B 97.00
Alcon (ALC) Switzerland $47.672B 33.56
IQVIA Holdings (IQV) United States $44.239B 25.07
IDEXX Laboratories (IDXX) United States $42.083B 50.62
Edwards Lifesciences (EW) United States $40.680B 26.07
DexCom (DXCM) United States $27.834B 39.69
STERIS (STE) Ireland $23.508B 27.43
SONOVA HOLDING (SONVY) Switzerland $20.781B 0.00
Waters (WAT) United States $19.789B 29.50
Hologic (HOLX) United States $18.981B 20.64
Sysmex ADR (SSMXY) Japan $12.317B 38.62
Fresenius Medical Care AG KGaA (FMS) Germany $12.224B 13.70
Teleflex (TFX) United States $11.380B 17.69
Globus Medical (GMED) United States $9.423B 26.36
Penumbra (PEN) United States $7.597B 78.86
Glaukos (GKOS) United States $6.721B 0.00
Masimo (MASI) United States $6.081B 32.57
TransMedics (TMDX) United States $5.203B 222.80
PROCEPT BioRobotics (PRCT) United States $4.309B 0.00
Integer Holdings (ITGR) United States $4.304B 25.17
Tandem Diabetes Care (TNDM) United States $2.791B 0.00
LivaNova (LIVN) United Kingdom $2.773B 16.26
Veracyte (VCYT) United States $2.593B 160.76
Inari Medical (NARI) United States $2.586B 0.00
Elekta AB (EKTAY) Sweden $2.562B 20.88
Nihon Kohden (NHNKY) Japan $2.508B 15.61
RxSight (RXST) United States $2.003B 0.00
Integra LifeSciences Holdings (IART) United States $1.360B 6.19
Pulse Biosciences (PLSE) United States $1.163B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.112B 19.84
Artivion (AORT) United States $1.046B 96.04
Alphatec Holdings (ATEC) United States $0.864B 0.00
OrthoPediatrics (KIDS) United States $0.728B 0.00
Mesa Laboratories (MLAB) United States $0.682B 17.23
SiBone (SIBN) United States $0.654B 0.00
AxoGen (AXGN) United States $0.638B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.616B 0.00
IRadimed (IRMD) United States $0.614B 33.19
Paragon 28 (FNA) United States $0.581B 0.00
Pacific Biosciences Of California (PACB) United States $0.526B 0.00
Treace Medical Concepts (TMCI) United States $0.341B 0.00
Sight Sciences (SGHT) United States $0.330B 0.00
Tactile Systems Technology (TCMD) United States $0.327B 9.98
ClearPoint Neuro (CLPT) United States $0.322B 0.00
AngioDynamics (ANGO) United States $0.306B 0.00
Inogen (INGN) United States $0.253B 0.00
Delcath Systems (DCTH) United States $0.251B 0.00
Nevro (NVRO) United States $0.217B 0.00
NeuroPace (NPCE) United States $0.199B 0.00
Accuray (ARAY) United States $0.190B 0.00
CVRx (CVRX) United States $0.189B 0.00
Atossa Genetics (ATOS) United States $0.179B 0.00
Semler Scientific (SMLR) United States $0.173B 12.15
Alpha Tau Medical (DRTS) Israel $0.162B 0.00
Spectral Diagnostics (EDTXF) Canada $0.135B 0.00
908 Devices (MASS) United States $0.128B 0.00
KORU Medical Systems (KRMD) United States $0.122B 0.00
EDAP TMS S.A (EDAP) France $0.114B 0.00
Monogram Orthopaedics (MGRM) United States $0.103B 0.00
Sensus Healthcare (SRTS) United States $0.099B 14.81
Hyperfine (HYPR) United States $0.070B 0.00
EnVVeno Medical (NVNO) United States $0.068B 0.00
InspireMD (NSPR) Israel $0.066B 0.00
WORK Medical Technology Group (WOK) China $0.063B 0.00
Covalon Technologies (CVALF) Canada $0.062B 0.00
Envoy Medical (COCH) United States $0.061B 0.00
LENSAR (LNSR) United States $0.049B 0.00
Lucid Diagnostics (LUCD) United States $0.045B 0.00
T2 Biosystems (TTOO) United States $0.038B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
Precision Optics (POCI) United States $0.035B 0.00
Accelerate Diagnostics (AXDX) United States $0.035B 0.00
Vicarious Surgical (RBOT) United States $0.034B 0.00
Adagio Medical Holdings (ADGM) United States $0.032B 0.00
Neuronetics (STIM) United States $0.029B 0.00
Lifeward (LFWD) United States $0.028B 0.00
DarioHealth (DRIO) United States $0.027B 0.00
Ekso Bionics Holdings (EKSO) United States $0.022B 0.00
Pixie Dust Technologies (PXDT) Japan $0.022B 0.00
Spectral AI (MDAI) United States $0.021B 0.00
PAVmed (PAVM) United States $0.017B 0.00
NexGel (NXGL) United States $0.016B 0.00
Autonomix Medical (AMIX) United States $0.016B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.010B 0.00
ReShape Lifesciences (RSLS) United States $0.005B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00